CD8+ T cells are an important component of the antiviral immune response. Much research effort is being invested in identifying new ways to boost antiviral immune responses in individuals with chronic viral infections. Although the use of the soluble factor IL-7 has proven attractive, new data indicate that the timing of IL-7 treatment is important in determining how effective it is at enhancing antiviral immunity.